Life Science Webinars

  1. Developability Screening Of Candidates With Combinatorial Stability Characterization 8/16/2023

    Full developability profiles de-risk the selection process for biologics candidates during early development workflows.

  2. Cell Therapy Milestones, Challenges, And Forming The Future Of TILs 8/15/2023

    What milestones enabled the evolution of TIL therapies? What does the future hold for TIL therapies? And where should you focus support for an accelerated path forward? Watch to explore these topics and more.

  3. Capabilities And Opportunities Of Innovative Cell Processing System In CGT 8/15/2023

    Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.

  4. Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS 8/11/2023

    Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.

  5. Maximizing The Value Of Your AAV Using Small Volume AAV Testing 8/11/2023

    Learn about MilliporeSigma's approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.

  6. Environmental Sustainability in Bioprocessing - On Demand 8/9/2023
  7. Data Integrity And Compliance In Bioanalysis 8/8/2023

    Learn how a combination of controlled compliant workflow execution, dramatically streamlined data acquisition and an “audit by exception” approach offers the next phase of innovation within bioanalysis.

  8. Solutions For Sustainable Chemistry And Supply Chain 7/31/2023

    Examine how a CRDMO committed to delivering innovative solutions can help meet the unique needs and requirements of clients in the pharmaceutical, biotechnology, and other industries.

  9. How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing 7/26/2023

    To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.

  10. The Role Of PUPSIT In A Contamination Control Strategy 7/25/2023

    Here, we discuss the relationship between the CCS and PUPSIT, highlight the role of sterilizing grade filtration in the control strategy, and talk about how this can change throughout the product life cycle.